3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
64
Head and Neck Neoplasms
63
Squamous Cell Carcinoma of Head and Neck
60
Carcinoma, Non-Small-Cell Lung
34
Rectal Neoplasms
23
Colonic Neoplasms
23
Neoplasm Metastasis
19
Neoplasms
18
Carcinoma, Squamous Cell
17
Pancreatic Neoplasms
13
Lung Neoplasms
13
Esophageal Neoplasms
11
Tongue Neoplasms
9
Stomach Neoplasms
9
Recurrence
9
Carcinoma
8
Neoplasms, Squamous Cell
6
Mouth Neoplasms
6
Laryngeal Neoplasms
6
Breast Neoplasms
6
Adenocarcinoma Of Esophagus
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Esophageal Squamous Cell Carcinoma
5
Adenocarcinoma of Lung
5
Sarcoma
4
Salivary Gland Neoplasms
4
Oropharyngeal Neoplasms
4
Laryngeal Diseases
4
Precancerous Conditions
3
Hypopharyngeal Neoplasms
3
Interventions
Nivolumab
4
pembrolizumab
3
pertuzumab
2
durvalumab
2
Paclitaxel
2
Docetaxel
2
Capecitabine
2
ulocuplumab
1
tremelimumab
1
tazarotene
1
talazoparib
1
romiplostim
1
pexidartinib
1
pamiparib
1
onartuzumab
1
magrolimab
1
entrectinib
1
cobimetinib
1
atezolizumab
1
Sunitinib
1
Rifampin
1
Ramucirumab
1
Radiosurgery
1
N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide
1
Midazolam
1
MK-4166
1
LY3022855
1
LY2510924
1
LY-2157299
1
Itraconazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Solid Tumor
×
Cetuximab
×
Clear all
No trials found.